Preimplantation Genetic Testing for Monogenic Disorders
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Preimplantation genetic testing (PGT) has evolved into a well-established alternative to invasive prenatal diagnosis, even though genetic testing of single or few cells is quite challenging. PGT-M is in theory available for any monogenic disorder for which the disease-causing locus has been unequivocally identified. In practice, the list of indications for which PGT is allowed may vary substantially from country to country, depending on PGT regulation. Technically, the switch from multiplex PCR to robust generic workflows with whole genome amplification followed by SNP array or NGS represents a major improvement of the last decade: the waiting time for the couples has been substantially reduced since the customized preclinical workup can be omitted and the workload for the laboratories has decreased. Another evolution is that the generic methods now allow for concurrent analysis of PGT-M and PGT-A. As innovative algorithms are being developed and the cost of sequencing continues to decline, the field of PGT moves forward to a sequencing-based, all-in-one solution for PGT-M, PGT-SR, and PGT-A. This will generate a vast amount of complex genetic data entailing new challenges for genetic counseling. In this review, we summarize the state-of-the-art for PGT-M and reflect on its future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unlike a monogenic (Mendelian) disease, AMD heritability is not controlled by a single mutation that can be identified from a pedigree analysis and observed in a family line [18,19].”
From Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians. (2024) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · cited 1×
“These loci are nuclear (X-linked, autosomal, dominantly or recessively inherited) or mitochondrial (maternally inherited) and involve (likely) pathogenic genetic variant(s) (class 4–5) [17].”
BackgroundPregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification
Handyside, A. H., Kontogianni, E. H., Hardy, K., & Winston, R. M. L. (1990) · Nature · doi:10.1038/344768a0 · Cited by 1,604
The International Glossary on Infertility and Fertility Care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.005 · Cited by 1,505
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320 · cited 15×
“These protocols often provide a tandem solution, combining PGT-A with PGT-M, and can be classified in two groups, depending on whether sequencing data for the monogenic locus are derived with a targeted or a genome-wide method.”
BackgroundInfluentialGenome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012) · Science · doi:10.1126/science.1229164 · Cited by 1,154 · cited 1×
“Both the Rubicon PicoPLEX and the MALBAC (Multiple Annealing and Looping Based Amplification Cycles) protocol initiate with DNA fragmentation and a pre-amplification MDA reaction using hybrid primers, followed by PCR [43,44].”
MethodReproductive Technologies and the Risk of Birth Defects
Davies, M. J., Moore, V. M., Willson, K. J., Van Essen, P., Priest, K., Scott, H., Haan, E. A., & Chan, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1008095 · Cited by 809 · cited 1×
“Studies showed that IVF and ICSI are associated with a small but statistically significant increase in congenital anomalies at birth, compared with the general population [60,61].”
BackgroundPandey, S., Shetty, A., Hamilton, M., Bhattacharya, S., & Maheshwari, A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms018 · Cited by 786 · cited 1×
“Studies showed that IVF and ICSI are associated with a small but statistically significant increase in congenital anomalies at birth, compared with the general population [60,61].”
BackgroundDe Rycke, M., Belva, F., Goossens, V., Moutou, C., SenGupta, S. B., Traeger-Synodinos, J., & Coonen, E. (2015) · Human Reproduction · doi:10.1093/humrep/dev122 · Cited by 703
Scott, R. T., Upham, K. M., Forman, E. J., Zhao, T., & Treff, N. R. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.039 · Cited by 574 · cited 1×
“A paired clinical trial showed that implantation rates of 50% in the nonbiopsied group were diminished to 30% in the cleavage-stage biopsy group, while similar implantation rates were obtained for the blastocyst-biopsy group versus the nonbiopsied group [29].”
ResultLaFramboise, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp552 · Cited by 467
Cited by
(2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.03.003 · Cited by 57
Volozonoka, L., Miskova, A., & Gailite, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094819 · Cited by 52
“Hence, MPS-based approaches are regarded as the most powerful platforms for future PGT [89].”
MethodPreimplantation Genetic Testing for Genetic Diseases: Limits and Review of Current Literature
Giuliano, R., Maione, A., Vallefuoco, A., Sorrentino, U., & Zuccarello, D. (2023) · Genes · doi:10.3390/genes14112095 · Cited by 65
“Preimplantation genetic testing for structural rearrangements (PGT-SR) has emerged as a promising technology in the field of reproductive medicine, allowing couples with chromosomal rearrangements to reduce the risk of transmitting genetic abnormalities to their offspring [11].”
BackgroundAnalysis of rare thalassemia genetic variants based on third-generation sequencing
Peng, C., Zhang, H., Ren, J., Chen, H., Du, Z., Zhao, T., Mao, A., Xu, R., Lu, Y., Wang, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14038-8 · Cited by 46
Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants
Vuković, P., Peccatori, F. A., Massarotti, C., Miralles, M. S., Beketić-Orešković, L., & Lambertini, M. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103201 · Cited by 43
PREIMPLANTATION GENETIC TESTING: clinical experience of preimplantation genetic testing
De Rycke, M., Berckmoes, V., De Vos, A., Van De Voorde, S., Verdyck, P., Verpoest, W., & Keymolen, K. (2020) · Reproduction · doi:10.1530/rep-20-0082 · Cited by 34
Classification of osteogenesis imperfecta: Importance for prophylaxis and genetic counseling
Pânzaru, M.-C., Florea, A., Caba, L., & Gorduza, E. V. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i12.2604 · Cited by 34
Pei, Z., Deng, K., Lei, C., Du, D., Yu, G., Sun, X., Xu, C., & Zhang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.810900 · Cited by 30
Embryo and fetal gene editing: Technical challenges and progress toward clinical applications
Mattar, C. N. Z., Chew, W. L., & Lai, P. S. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101229 · Cited by 26
“12 This technology may be particularly attractive to carrier couples who wish to avoid terminating an affected pregnancy.”
BackgroundAutosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances
Borghol, A. H., Antoun, M. T. B., Hanna, C., Salih, M., Rahbari-Oskoui, F. F., & Chebib, F. T. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2492374 · Cited by 23
Doroftei, B., Ilie, O., Anton, N., Armeanu, T., & Ilea, C. G. (2022) · Diagnostics · doi:10.3390/diagnostics12081911 · Cited by 25
“Thus, the current method of choice surrounding assisted reproductive technologies (ARTs) is IVF combined with PGT to minimize the risks of genetically abnormal embryo(s) [2].”
MethodPeng, C., Chen, H., Ren, J., Zhou, F., Li, Y., Keqie, Y., Ding, T., Ruan, J., Wang, H., Chen, X., et al. (2023) · BMC Genomics · doi:10.1186/s12864-023-09593-x · Cited by 19
Genetic counseling for pre-implantation genetic testing of monogenic disorders (PGT-M)
Parikh, F. R., Athalye, A. S., Madon, P. F., Khandeparkar, M. S., Naik, D. J., Sanap, R. R., & Udumudi, A. (2023) · Frontiers in Reproductive Health · doi:10.3389/frph.2023.1213546 · Cited by 21
“PGT-M is presently available for identifying pathogenic or likely pathogenic disease causing variants in embryos for all known monogenic disorders (18).”
BackgroundAssisted Reproductive Technology: A Ray of Hope for Infertility
Tenchov, R., & Zhou, Q. A. (2025) · ACS Omega · doi:10.1021/acsomega.5c01643 · Cited by 33
Preimplantation genetic testing: a review of current modalities
Harris, B. S., Bishop, K. C., Kuller, J. A., Alkilany, S., & Price, T. M. (2020) · F&S Reviews · doi:10.1016/j.xfnr.2020.10.001 · Cited by 21
Fr, P., Athalye, A., Kulkarni, D., Sanap, R. R., Dhumal, S., Warang, D., Naik, D., & Madon, P. F. (2021) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_148_21 · Cited by 21
“The genomic coverage or read depth refers to the number of reads found at a given position.[24] A low coverage is sufficient for PGT‐A.”
BackgroundThompson, W. S., Babayev, S. N., McGowan, M. L., Kattah, A. G., Wick, M. J., Bendel‐Stenzel, E., Chebib, F. T., Harris, P. C., Dahl, N. K., Torres, V. E., et al. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000253 · Cited by 18
Mitochondria in biology and medicine – 2023
Disha, B., Mathew, R. P., Dalal, A. B., Mahato, A. K., Satyamoorthy, K., Singh, K. K., Thangaraj, K., & Govindaraj, P. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101853 · Cited by 23
Evolution of Minimally Invasive and Non-Invasive Preimplantation Genetic Testing: An Overview
Moustakli, E., Zikopoulos, A., Skentou, C., Bouba, I., Dafopoulos, K. C., & Georgiou, I. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082160 · Cited by 25
“…in theory, irrespective of the initial indication for PGT—either monogenic disorders (PGT-M) or structural rearrangements (PGT-SR)—next-generation sequencing (NGS) would result in a diagnostic yield that also covered partial-or whole-chromosome aneuploidies (PGT-A), and vice versa (Figure 1) [9].”
BackgroundInfluentialPreimplantation genetic testing in assisted reproduction
Madero, J. I., Manotas, M. C., García-Acero, M., López, A., & JAIMES, C. L. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04805-3 · Cited by 22
Fertility counseling in women with hereditary cancer syndromes
Somigliana, E., Costantini, M. P., Filippi, F., Terenziani, M., Riccaboni, A., Nicotra, V., Rago, R., Paffoni, A., Mencaglia, L., Magnolfi, S., et al. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103604 · Cited by 24
He, W., Xiao, W.-J., Dai, C., Wang, Y., Li, X., Gong, F., Meng, L., Tan, C., Zeng, S., Lu, G., et al. (2022) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2021-108013 · Cited by 18
Hemoglobinopathies and preimplantation diagnostics
Mamas, T., Kakourou, G., Vrettou, C., & Traeger‐Synodinos, J. (2022) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13851 · Cited by 18
“Currently, hemoglobinopathies together with cystic fibrosis are the most common indications for PGT-M for autosomal recessive disorders.(27)”
BackgroundAlbujja, M. H., Ghedan, M. A., Dakshnamoorthy, L., & Victori, J. P. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.05.002 · Cited by 16
Chinese experts’ consensus guideline on preimplantation genetic testing of monogenic disorders
Yan, L., Cao, Y., Chen, Z., Du, J., Wang, S., Huang, H., Huang, J., Li, R., Liu, P., Zhang, Z., et al. (2023) · Human Reproduction · doi:10.1093/humrep/dead112 · Cited by 16
Fetal Wellbeing Monitoring – A Review Article
Jain, S., & Acharya, N. (2022) · Cureus · doi:10.7759/cureus.29039 · Cited by 23
“Genotype, as well as chromosome copy number, is obtained after the test result [8].”
BackgroundPreimplantation Genetic Testing for Kidney Disease-Related Genes: A Laboratory’s Experience
Chaperon, J. L., Wemmer, N., McKanna, T. A., Clark, D. M., Westemeyer, M. A., Gauthier, P., Bai, Y., & Coleman, J. M. (2021) · American Journal of Nephrology · doi:10.1159/000518253 · Cited by 15
An Update on Non-invasive Approaches for Genetic Testing of the Preimplantation Embryo
Kakourou, G., Mamas, T., Vrettou, C., & Traeger‐Synodinos, J. (2022) · Current Genomics · doi:10.2174/1389202923666220927111158 · Cited by 20
“Chromosomal analysis initially involved the use of Fluorescent In Situ Hybridization (FISH) for testing a subset of chromosomes but quickly moved to new diagnostic techniques that enable comprehensive chromosomal analysis, such as array comparative genomic hybridization (aCGH), quantitative PCR (which amplifies a limi…”
BackgroundInfluentialUpdates in preimplantation genetic testing (PGT)
Petch, S., & Crosby, D. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102526 · Cited by 19
The embryo non-invasive pre-implantation diagnosis era: how far are we?
del Collado, M., Andrade, G. M., Gonçalves, N. J. N., Fortini, S., Perecin, F., & Carriero, M. M. (2023) · Animal Reproduction · doi:10.1590/1984-3143-ar2023-0069 · Cited by 13
Pickart, A. M., Martin, A. S., Gross, B. N., Dellefave‐Castillo, L. M., McCallen, L. M., Nagaraj, C. B., Rippert, A. L., Schultz, C., Ulm, E. A., & Armstrong, N. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1892 · Cited by 13
“Given the costs and complexities of this testing, PGT laboratories may be unable or unwilling to perform PGT-M for potential germline mosaicism, until such mosaicism has been demonstrated by the birth of another child with the pathogenic variant (De Rycke & Berckmoes, 2020).”
Preconception carrier screening and preimplantation genetic testing in the infertility management
Caroselli, S., Poli, M., Gatta, V., Stuppia, L., & Capalbo, A. (2024) · Andrology · doi:10.1111/andr.13744 · Cited by 13
“73,74 Historically, PGT-M was applied for the first time on humans in 1990, 75 when the genetic analysis of embryos from patients carrying X-linked recessive genetic diseases allowed the identification and selective transfer of female embryos (avoiding hemizygous males with 50% risk of manifesting…”
Abnormalities of pubertal development and gonadal function in Noonan syndrome
Patti, G., Scaglione, M., Maiorano, N. G., Rosti, G., Divizia, M. T., Camia, T., Rose, E. L. D., Zucconi, A., Casalini, E., Napoli, F., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1213098 · Cited by 16
“PGT is performed on embryo biopsy and afterwards, only non-affected embryos are transferred to the uterus (28, 41).”
BackgroundGenetics and Age-Related Macular Degeneration: A Practical Review for Clinicians.
Nguyen, J., Brantley, & Schwartz, S. G. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1601003 · Cited by 12
“Unlike a monogenic (Mendelian) disease, AMD heritability is not controlled by a single mutation that can be identified from a pedigree analysis and observed in a family line [ 18,19].”
BackgroundPrenatal and preimplantation genetic testing for monogenic kidney disorders
Knoers, N. V. A. M. (2024) · Kidney International · doi:10.1016/j.kint.2024.06.031 · Cited by 14
Hugon, A. M., & Golos, T. G. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad042 · Cited by 11
Bunnell, M. E., Dobson, L. J., Lanes, A., & Ginsburg, E. S. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6189 · Cited by 10
“This is both a strength in that the data represents a long period of practice habits and decision‐making, but also a limitation in that the technology and practice patterns changed in multiple ways throughout the study period, with shifts in diagnostic methods making today's PGT‐M techniques more accurate than those u…”
BackgroundMethodInfluentialBackenroth, D., Altarescu, G., Zahdeh, F., Mann, T., Murik, O., Renbaum, P., Segel, R., Zeligson, S., Hakam-Spector, E., Carmi, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-45292-z · Cited by 9
“For a recent review, see reference 14 .”
Grati, F. R., Capalbo, A., Gabbiato, I., Battaglia, P., Pittalis, M. C., Bizzoco, D., Cardarelli, L., Gatta, V., Lonardo, F., Novelli, A., et al. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03358-5 · Cited by 9
“In order to assess the feasibility of PGT-M during pre-PGT genetic counselling, it is necessary to know the molecular basis of the familial disease [12].”
Li, J., Cui, Y., Shi, H., Bu, Z., Wang, F., Sun, B., & Zhang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.990971 · Cited by 9
“Patients with advanced age, recurrent pregnancy loss (RPL), and recurrent implantation failure (RIF) are the key target populations for PGT-A (16); PGT-SR is primarily utilized in the detection of chromosomal diseases, including abnormalities in the number of chromosomes, such as Klinefelter syndrome (47, XXY), and ab…”
BackgroundHuang, X., Rui, X., Zhang, S., Qi, X., Rong, W., & Sheng, X. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01516-9 · Cited by 8
Wang, Y., Li, Y., Zhu, X., Yang, M., Liu, Y., Wang, N., Long, C., Kuo, Y., Lian, Y., Huang, J. H., et al. (2024) · Advanced Science · doi:10.1002/advs.202309817 · Cited by 9
Tóth, T., Csaba, Á., Bokor, A., & Ács, N. (2023) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2023.101910 · Cited by 8
Rubio, C., & Simón, C. (2021) · Genes · doi:10.3390/genes12010118 · Cited by 8
“A review for genetic disorders covers the evolution of this technology as an established alternative to invasive prenatal diagnosis, as well as future innovations [4].”
BackgroundBarrett, F., Shaw, J., Besser, A. G., GRIFO, J. A., & Blakemore, J. K. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02925-6 · Cited by 7
“In addition, the majority of PGT-M cycles for BRCA1/2 variants occurred later in the study time period, between 2018 and 2021, suggesting a shift in utilization or an increase in incidence of diagnosis due to increased genetic testing [28].”
BackgroundHuang, P., Lan, Y., Zhou, H. H., Lin, L., Shu, J., Wang, C., Zhao, X., Liang, L., He, S., Mou, J., et al. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2293 · Cited by 7
“Nonetheless, the cost of NGS is generally lower than that of SNP array for detecting common monogenic diseases (De Rycke & Berckmoes, 2020).”
BackgroundGender equity in hemophilia: need for healthcare, familial, and societal advocacy
Gualtierotti, R., Garagiola, I., Mortarino, M., Spena, S., Romero‐Lux, O., & Peyvandi, F. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1345496 · Cited by 13
Karami, N., Iravani, F., Bavarsad, S. B., Asadollahi, S., Hoseini, S. M., Montazeri, F., & Kalantar, S. M. (2024) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v22i3.16161 · Cited by 8
“PGT for single gene/monogenic disorders (PGT-M), formerly known as PGD, is an early genetic diagnosis test for a single defective gene that can be inherited from a parent in a carrier family or formed during germ-line development (12–14).”
BackgroundHereditary Neuromuscular Disorders in Reproductive Medicine
Luglio, A., Maggi, E., Riviello, F. N., Conforti, A., Sorrentino, U., & Zuccarello, D. (2024) · Genes · doi:10.3390/genes15111409 · Cited by 11
“PGT can be applied to most couples (with deletions or point variants), and segregation of the mutant allele of the SMN1 gene can be performed both with a direct method (variant analysis) and an indirect method (risk haplotype analysis) [156].”
Latham, K. E. (2024) · Molecular Reproduction and Development · doi:10.1002/mrd.23727 · Cited by 6
“PGT for HLA typing, a controversial approach proposed as an option for producing sibling tissue donors (De Rycke & Berckmoes, 2020; Wang et al., 2020; Xie et al., 2022), could become irrelevant if sufficient progress is made in stem ‐ cell biology and gene therapy methods, and artificial gametes…”
BackgroundMethodInfluentialExtended application of PGT-M strategies for small pathogenic CNVs
Hu, X., Wang, W., Luo, K., Dai, J., Zhang, Y., Wan, Z., He, W., Zhang, S., Yang, L., Tan, Q., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03028-6 · Cited by 6
“PGT has been used to prevent birth defects, increase the chances of a successful pregnancy, and reduce the occurrence of spontaneous abortions since 1990s [8].”
Moustakli, E., Gkountis, A., Dafopoulos, S., Zikopoulos, A., Sotiriou, S., Zachariou, A., & Dafopoulos, K. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011296 · Cited by 7
“The process involves an initial IVF/ICSI procedure, followed by a biopsy of embryonic cells, and then PGT to selectively transfer an unaffected embryo [36].”
MethodRen, J., Peng, C., Zhou, F., Li, Y., Keqie, Y., Chen, H., Zhu, H., Chen, X., & Liu, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.926060 · Cited by 6
Lin, T., Luo, J., Yu, H., Dong, B., Zhang, Q., Zhang, W., Chen, K. G., Xiang, Y., Liu, D., & Huang, G. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02722-1 · Cited by 6
Reproductive Choices in Haemoglobinopathies: The Role of Preimplantation Genetic Testing
Kakourou, G., Vrettou, C., Mamas, T., & Traeger‐Synodinos, J. (2025) · Genes · doi:10.3390/genes16040360 · Cited by 7
“Concurrent testing for all PGT indications (PGT-M, PGT-A, and PGT-SR) has become possible from a single biopsy sample [62].”
Rajanikanth, G., Prangley, A., Stransky, O. M., Langfelder-Schwind, E., Vento, J. M., Felter, E. M., & Kazmerski, T. M. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251340334 · Cited by 5
Zhang, P., Wu, B., Wang, Y., Ren, Y., Li, G., Qan, Y., Lei, C., & Wang, H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00898-y · Cited by 5
Human embryos donated for human embryonic stem cell derivation
Salari, S. M., Adashi, E. Y., Keller, L., Johnson, T. R. B., & Smith, G. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.10.023 · Cited by 5
Preimplantation Genetic Testing in a Family with Neurofibromatosis Type 1
Wang, L., He, X., Huang, X., Qiu, P., Ji, H., Ding, L., Shi, Y., Li, P., & Mei, L. (2025) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2025.0031 · Cited by 4
Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis
Combs, J. C., Dougherty, M., Yamasaki, M. U., DeCherney, A. H., Devine, K., Hill, M. J., Rothwell, E., O’Brien, J. E., & Nelson, R. E. (2023) · F&S Reports · doi:10.1016/j.xfre.2023.06.001 · Cited by 7
Banu, M., Pathan, A. A. K., & Chaitanya, K. V. (2023) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2646 · Cited by 4
Wen, X., Li, Z., Cheng, L., Huo, J., Yu, W.-J., Ou, Z., Liu, N., Li, J., Fang, X., & Lin, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1441014 · Cited by 4
Zhang, L., Feng, L., Shi, H., Niu, W., Wang, Y., Bu, B., Liu, Y., Bao, X., Song, W., Jin, H., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03525-y · Cited by 4
“…assisted reproductive technology in which single or several cells of in vitro fertilized embryos from patients with monogenetic defects are biopsied, genetic detection of the biopsied samples is performed, and unaffected embryos are selectively transferred to prevent disease inheritance [11, 12].”
The goal of embryo diagnostics and prognostics testing
de Ziegler, D., Dokras, A., Fox, C. W., & Pirtea, P. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.07.1218 · Cited by 5
Preimplantation genetic diagnosis
Tokhy, O. E., Salman, M., & El‐Toukhy, T. (2021) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2021.04.003 · Cited by 4
GM1 gangliosidosis: patients with different phenotypic features and novel mutations
Şanlı, M. E., & Dogan, M. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0630 · Cited by 4
Benammar, A., Münnich, A., Poulain, M., Magnan, F., Racowsky, C., & Ayoubi, J.-M. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02802-2 · Cited by 4
Lima, N. S., Zappala, M. A. P., Delvitto, A., Romero, M. A., & Pallitto, N. (2023) · Salud Colectiva · doi:10.18294/sc.2023.4481 · Cited by 6
Lin, T., Ma, Y., Zhou, D., Sun, L., Chen, K., Xiang, Y., Tong, K., Jia, C.-L., Kean, J., Liu, D., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.843931 · Cited by 6
Shi, Q., Xie, T., Li, J., Li, N., Xu, C., Lin, Z., Huang, Y., Zhou, L., Mao, A., Li, J., et al. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03552-z · Cited by 4
“Therefore, couples who are α-thalassemia carriers and at risk of conceiving pregnancies affected by Hb Bart’s and Hb H disease may benefit from preimplantation genetic testing for monogenic diseases (PGT-M) [6].”
Wang, J., Xing, J., Chen, L., Diao, Z., He, L., Wang, S., Lin, F., & Zhang, N. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07773-y · Cited by 3
“…(PGT) can be performed for monogenic disorders that has unequivocally identified disease-causing locus, which involves the biopsy of a few cells from preimplantation embryos and testing of the biopsied samples for pathogenic mutations followed by the selective transfer of unaffected embryos [4, 5].”
Vaiarelli, A., Cimadomo, D., Blancafort, C., Trabucco, E., Alviggi, E., Vallefuoco, R., Livi, C., Benini, F., Canosa, S., Llácer, J., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.11.003 · Cited by 3
Zhang, S., Zhu, J., Qi, H., Xu, L., Cai, L., & Meng, R. (2021) · Molecular Cytogenetics · doi:10.1186/s13039-021-00576-9 · Cited by 3
“ish t(1;3) (VIJyRM2123-,3QTEL05 + ;3QTEL05,VIJyRM2123 +)[8] /1p36.”
Vuong, V. V. H., Tran, T. H., Nguyen, P., Thi, N. N., Thi, P. L., Nguyet, D. T. M., Nguyen, M.-H., Bui, T., Ta, T. V., & Tran, V.-K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278539 · Cited by 3
Huntington's disease: Clinical features, genetic diagnosis, and brain imaging
Estevez‐Fraga, C., Nakajima, M., & Tabrizi, S. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00010-8 · Cited by 4
Scriven, P. N. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02398-z · Cited by 3
Suppression of trinucleotide repeat expansion in spermatogenic cells in Huntington’s disease
Cho, I. K., Easley, C. A., & Chan, A. W. S. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-022-02594-x · Cited by 4
Evidence-Based Reporting in Preimplantation Genetic Testing (PGT)
Poli, M., Picchetta, L., Siciliani, L., & Capalbo, A. (2025) · Genes · doi:10.3390/genes16091083 · Cited by 2
“NGS-based approaches for PGT-M involve the targeted amplification of the relevant gene region, facilitating the simultaneous analysis of both the pathogenic mutation and its associated flanking markers [15].”
InfluentialÜnsal, E., Özer, L., Baltacı, V., Duman, T., Halıcıgil, C., Koc, Z., Saglam, A. B., Buyuk, P., Baris, S., & Aktuna, S. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03676-2 · Cited by 3
Optimisation of Laser‐Assisted Biopsy Parameters in Bovine Embryos
Zhang, J., Shen, H., Zhang, Z., Tian, J., An, L., & Wang, Y. (2026) · Reproduction in Domestic Animals · doi:10.1111/rda.70184 · Cited by 2
“…2023; Persico et al. 2023; De Vos and De Munck 2025) and preimplantation aneuploidy screening (PGT-A) (Kimelman and Pavone 2021; Nair et al. 2022), effectively preventing transmission of hereditary diseases and reducing pregnancy losses (De Rycke and Berckmoes 2020; Fernandes and De Carvalho 2024).”
Chen, X., Peng, C., Chen, H., Zhou, F., Keqie, Y., Li, Y., Liu, S., & Ren, J. (2024) · Medicine · doi:10.1097/md.0000000000037198 · Cited by 2
“[18] Theoretically speaking, PGT-M can be used for any monogenic disorders where the disease-causing locus is clearly identified.”
BackgroundGenetic Diagnosis and Counseling in Muscular Dystrophies
Smith, K., & Wicklund, M. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_14 · Cited by 3
Zhang, Z., Zhang, X., Xue, H., Chu, L., Hu, L., Bi, X., Zhu, P., Zhang, D., Chen, J., Cui, X., et al. (2024) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2409 · Cited by 2
“By selecting euploid embryos without these variants for transfer, PGT-M prevents the transmission of monogenic diseases and ultimately results in the birth of a healthy child (De Rycke & Berckmoes, 2020; Du et al., 2023).”
BackgroundKelen, A. V. D., Keymolen, K., Cools, W., Vos, A. D., Pölsler, L., Vos, M. D., Blockeel, C., Fernandez-Gallardo, E., Rycke, M. D., Berckmoes, V., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03141-6 · Cited by 2
Self-citationYang, J., Shi, H., Niu, W., Bao, X., Liu, H., Chen, C., Jin, H., Song, W., & Sun, Y. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02812-0 · Cited by 2
Should non-invasive prenatal testing be recommended for patients who achieve pregnancy with PGT?
Liang, Y., Li, M., Fei, J., & Chen, Z. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06284-7 · Cited by 2
Holtzman, S., McCarthy, L., Estevez, S. L., Lee, J. A., Baird, M., Gounko, D., Copperman, A. B., & Blank, S. V. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.03.025 · Cited by 2
Robotic Manipulation of Cumulus–Oocyte Complexes for Cumulus Cell Removal
Zhai, R., Hao, M., Wang, Y., Ru, C., & Zhu, J. (2024) · Applied Sciences · doi:10.3390/app14188450 · Cited by 1
Ma, B., Hong, Z., Zhang, L., Ma, L., Duan, J., Gao, Y., Wang, M., & Zhang, Y. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01761-y · Cited by 1
“PGT is an essential tool for preventing chromosomal aneuploidies and other genetic disorders, including monogenic diseases (PGT-M) [6 , 7 ].”
Kim, M. J., Hong, Y., Han, G., Lee, H.-S., Park, E. A., Lee, K., Yu, E. J., & Kang, I. S. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15070273 · Cited by 1
Vernimmen, V., Rycke, M. D., Moutou, C., Dreesen, J. C. F. M., Blok, M. J., van Minkelen, R., Lauer-Zillhardt, J., Verdyck, P., Keymolen, K., van Uum, C. M. J., et al. (2025) · Human Reproduction · doi:10.1093/humrep/deaf224 · Cited by 1
“Additional markers, number ranging from 2 to 14, were added if the SNP loci of the resulting karyomap were insufficiently informative (Handyside et al. , 2010; Natesan et al. , 2014; De Rycke and Berckmoes, 2020).”
Li, Z., Lin, X., 张旭宾, Fang, X., Ou, Z., Huo, J., Ke, W., Wu, J., Yu, W., Ma, L., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1881113 · Cited by 1
“Preimplantation genetic testing (PGT) addresses this challenge by screening embryos for chromosomal abnormalities and selecting euploid embryos for transfer, thereby improving pregnancy rates per transfer cycle in speci fi c populations (1, 2).”
Preimplantation genetic diagnosis
Tokhy, O. E., Salman, M., & El‐Toukhy, T. (2024) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2023.12.004 · Cited by 1
Understanding and managing patients with adult rare diseases
Moon, J. (2024) · Journal of genetic medicine · doi:10.5734/jgm.2024.21.1.1 · Cited by 1
“It also provides an opportunity opens up opportunities to explore reproductive options [34].”
Huang, Z., Ding, T., Ni, Z., Zheng, Y., Liu, N., Li, T., Lian, W., Zheng, B., & Sun, Y. P. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.101962 · Cited by 1
“…[6], and through the amplification and sequencing of the whole-genome amplification (WGA) products of a few embryo biopsy cells [7,8], preimplantation genetic testing for aneuploidy (PGT-A) can be conducted to select healthy embryos with normal copy number variants (CNVs) for implantation [9,10].”
Raine, S. R., Siegel, D. R., Rabkina, L., Nassab, P., Cerveró, A., Martínez-Conejero, J. A., Elfman, H., & Polotsky, A. J. (2025) · F&S Reports · doi:10.1016/j.xfre.2025.03.007 · Cited by 1
“According to De Rycke and Berckmoes (3), ‘‘ Exclusion testing is indirect, based only on genetic markers, and involves the transfer of embryos carrying a haplotype derived from the embryologic nonaffected grandparent or affected grandparent.”
InfluentialChen, J., Wu, X., Xu, Q., Ding, T., Chen, G., Chen, H., Zou, Y., Huang, J., Zhang, Z., Tian, L., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03659-7 · Cited by 1
Clinical validation of embryo prognostic tests; determining predictive value: phase 2
Pirtea, P., Su, I. H., Toft, C. L. F., & Kalafat, E. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.08.011 · Cited by 1
Congenital Abnormalities: Prenatal Diagnosis and Screening
Barnett, C. (2022) · Springer eBooks · doi:10.1007/978-3-030-84168-3_8 · Cited by 1
Preimplantation genetic testing for monogenic diseases—bench to bedside reflections
Dokras, A., & Barlow, D. H. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.09.008 · Cited by 1
Metadata
- Authors
- De Rycke, M., & Berckmoes, V.
- Affiliations
- Center for Medical Genetics, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
- Universitair Ziekenhuis Brussel (BE)
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-07-31
- Volume
- 11
- Issue
- 8
- Pages
- 871
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC7463885
- OpenAlex
- W3022322625
- Cited by
- 140
- References
- 75
- Citations by year
- 2026: 15 · 2025: 24 · 2024: 35 · 2023: 35 · 2022: 20 · 2021: 8 · 2020: 3
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- preimplantation genetic testing, monogenic disorders, preimplantation genetic testing for monogenic disorders, preimplantation genetic testing for aneuploidy, preimplantation genetic testing for structural rearrangements, whole genome amplification, SNP array, next-generation sequencing, genetic counseling
- MeSH terms
- Genetic Testing, Humans, Sequence Analysis, DNA, Preimplantation Diagnosis, Reproductive Techniques, Assisted, Genetic Diseases, Inborn
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.